/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $515M · 0.50% margin · $17M FCF
Operating margin is thin at 7.92%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 17.0% YoY with margins expanding 8.2pp. However, free cash flow softened 686%, worth monitoring whether this is timing or structural.
Free cash flow declined 686% versus the prior year, cash generation momentum has weakened. Negative free cash flow of -$24M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$515M
▲ +17.0% YoY
Net Income (TTM)
$3M
▲ +4201.0% YoY
Op. Margin
0.50%
▲ +8.2pp YoY
ROIC
0.66%
▲ +9.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$17M
▼ -685.7% YoY
Op. Cash Flow (TTM)
$31M
▼ -172.6% YoY
Net Debt
-$52M
Net Cash Position
Cash & Equiv.
$91M
5Y CAGR: +10.8%
Continue Research